|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Feb 28, 2025
|
FY2024
12 months to Feb 29, 2024
|
FY2023
12 months to Feb 28, 2023
|
FY2022
12 months to Feb 28, 2022
|
|
|---|---|---|---|---|---|
| Cash provided by operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of financing costs | |||||
| Non-cash operating lease expense | |||||
| Provision for credit losses | |||||
| Non-cash share-based compensation | |||||
| Non-cash restructuring charges | |||||
| Asset impairment charges | |||||
| Loss on extinguishment of debt | |||||
| Gain on sale of distribution and office facilities | |||||
| Gain on sale of Personal Care business | |||||
| Gain on the sale or disposal of property and equipment | |||||
| Deferred income taxes and tax credits | |||||
| Changes in operating capital, net of effects of acquisition of businesses: | |||||
| Receivables | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other assets and liabilities, net | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Accrued income taxes | |||||
| Net cash provided by operating activities | |||||
| Cash (used) provided by investing activities: | |||||
| Capital and intangible asset expenditures | |||||
| Net proceeds (payments) from business acquired | |||||
| Payments for purchases of U.S. Treasury Bills | |||||
| Proceeds from maturities of U.S. Treasury Bills | |||||
| Proceeds from sale of distribution and office facilities | |||||
| Proceeds from the sale of property and equipment | |||||
| Proceeds (payments) from promissory note | |||||
| Net cash (used) provided by investing activities | |||||
| Cash (used) provided by financing activities: | |||||
| Proceeds from revolving loans | |||||
| Repayment of revolving loans | |||||
| Proceeds from term loans | |||||
| Repayment of long-term debt | |||||
| Payment of financing costs | |||||
| Proceeds from share issuances under share-based compensation plans | |||||
| Payments for repurchases of common stock | |||||
| Net cash (used) provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning balance | |||||
| Cash and cash equivalents, ending balance | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid, net of refunds | |||||
| Supplemental non-cash investing activity: | |||||
| Capital expenditures included in accounts payable and accrued expenses |
Loading...